Huffington Post Blog

Entries from Dr. Brggin’s Huffington Post blog are mirrored here.

Jury Awards $1.5 million for suicide involving antidepressants based on Dr. Breggin’s testimony

A Syracuse, N.Y. jury has awarded a $1.5 million medical malpractice verdict to the family of a man who committed suicide. I was the medical expert for the family. After the verdict, plaintiff’s attorney Ernest DelDuchetto told me, “It was comforting to see a jury agree with our proposition that these drugs (antidepressants) are not panaceas for all sadness,” and that they can have serious harmful effects.

Read More

Today’s Greatest Mental Health Need: Psychiatric Drug Withdrawal Programs

The pharmaceutical industry and organized psychiatry act as if the greatest challenge today is to identify new psychiatric disorders, to promote the supposedly high prevalence of existing disorders, and to find new blockbuster drugs, all the while heavily promoting current moneymakers. Even the United Nations is involved in “World Mental Health Day,” announcing that depression is a “global health crisis”:

Read More

Inside Psychiatry: Anxiety Over Antipsychotic Drugs

Children throughout America are being given these drugs for everything from insomnia to ADHD. Some of these children are developing horrific side adverse effects, including gynecomastia in preadolescent boys and girls who develop breasts indistinguishable from those of adult women. Sometimes these breasts grow back after surgical removal, despite stopping the medications.

Read More

Soaring Numbers of Children on Powerful Adult Psychiatric Drugs

A recent blog of mine described how unethical and illegal drug company activities have driven the prescription of toxic antipsychotic drugs to children. Now the “success” of this campaign has been documented in the Archives of General Psychiatry. In a comparison between the years 1993-1998 and 2005-2009, prescriptions of antipsychotic drugs for per 100 children (0-13 years old) rose from 0.24 to 1.83. That’s more than a sevenfold increase.

Read More

Drug Companies Drive the Psychiatric Drugging of Children

Johnson & Johnson, the company that makes the antipsychotic drug Risperdal, has tentatively agreed to a settlement of $2.2 billion to resolve a federal investigation into the company’s marketing practices. Although details are not fully finalized, this includes “a roughly $400 million criminal fine for the illegal promotion of the antipsychotic Risperdal,” according to the Wall Street Journal. It’s been well documented that Johnson & Johnson confidentially paid psychiatrists such as Harvard’s Joseph Biederman to promote adult drugs such as the powerful antipsychotic drug Risperdal for children. The company has even ghost-written at least one of the Harvard professor’s “scientific” articles.

Read More

Drug Company GlaxoSmithKline Puts American Values to Shame

As described in my previous blog, during this same period of time the U.S. Department of Justice (DOJ) began a lengthy investigation of Glaxo, resulting in recent civil and criminal fines of $3 billion for improper off-label marketing of the antidepressants Paxil and Wellbutrin, and Advair. (Although recording-breaking, the penalty was paltry in comparison to sales for the three drugs, with Advair by itself pulling in considerably more than twice that much per year for several years.)

Read More

New Study Confirms Electroshock (ECT) Causes Brain Damage

A new study shows ECT (electroconvulsive therapy) causes brain damage? That’s not what you will find in the many promotional press releases published in the mainstream media. As usual, biopsychiatric press releases always come out before the research articles are easily available, making critical analysis impossible until the wave of false promotional euphoria has passed.

Read More